Lothar Germeroth und Stage Person-Info 

( Ich bin Lothar Germeroth)
(1 - 12 von 14
)

Mit Streptamer isolierte Donor-Lymphozyten wurden von der EMEA ...

www.bionity.com
Streptamer-Technologie als einzigartiges Konzept für eine qualitativ hochwertige und ökonomische Herstellung von Zellthe…utika stark voran getrieben wird“, sagte Dr. Lothar Germeroth, Geschäftsführer von STAGE.

Juno The…utics Strengthens Multiple Capabilities Through...

Juno The…utics Strengthens Multiple Capabilities Through Acquisition of Stage Cell The…utics

Streptamer isolated donor lymphocytes classified by the EMEA as non...

www.bionity.com
“We believe that the decision of the EMEA will strongly support our Streptamer technology as a unique platform for high quality and economic generation of cell the…utics” said Dr. Lothar Germeroth, COO of STAGE. Streptamer-isolated cells are currently investigated in several clinical studies for treatment of …

Juno The…utics acquires biotech company, Stage Cell The…utics

www.pharmabiz.com
Juno The…utics acquires biotech company, Stage Cell The…utics
+1